Literature DB >> 18780834

Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.

Kamaleldin E Elagib1, Ivailo S Mihaylov, Lorrie L Delehanty, Grant C Bullock, Kevin D Ouma, Jill F Caronia, Sara L Gonias, Adam N Goldfarb.   

Abstract

The transcription factor GATA-1 participates in programming the differentiation of multiple hematopoietic lineages. In megakaryopoiesis, loss of GATA-1 function produces complex developmental abnormalities and underlies the pathogenesis of megakaryocytic leukemia in Down syndrome. Its distinct functions in megakaryocyte and erythroid maturation remain incompletely understood. In this study, we identified functional and physical interaction of GATA-1 with components of the positive transcriptional elongation factor P-TEFb, a complex containing cyclin T1 and the cyclin-dependent kinase 9 (Cdk9). Megakaryocytic induction was associated with dynamic changes in endogenous P-TEFb composition, including recruitment of GATA-1 and dissociation of HEXIM1, a Cdk9 inhibitor. shRNA knockdowns and pharmacologic inhibition both confirmed contribution of Cdk9 activity to megakaryocytic differentiation. In mice with megakaryocytic GATA-1 deficiency, Cdk9 inhibition produced a fulminant but reversible megakaryoblastic disorder reminiscent of the transient myeloproliferative disorder of Down syndrome. P-TEFb has previously been implicated in promoting elongation of paused RNA polymerase II and in programming hypertrophic differentiation of cardiomyocytes. Our results offer evidence for P-TEFb cross-talk with GATA-1 in megakaryocytic differentiation, a program with parallels to cardiomyocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780834      PMCID: PMC2597596          DOI: 10.1182/blood-2008-03-145722

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.

Authors:  E Ito; M Kasai; Y Hayashi; T Toki; K Arai; S Yokoyama; K Kato; N Tachibana; M Yamamoto; M Yokoyama
Journal:  Br J Haematol       Date:  1995-07       Impact factor: 6.998

2.  Consequences of GATA-1 deficiency in megakaryocytes and platelets.

Authors:  P Vyas; K Ault; C W Jackson; S H Orkin; R A Shivdasani
Journal:  Blood       Date:  1999-05-01       Impact factor: 22.113

3.  A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development.

Authors:  R A Shivdasani; Y Fujiwara; M A McDevitt; S H Orkin
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

Review 4.  Flavopiridol, an inhibitor of transcription: implications, problems and solutions.

Authors:  Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2004-12-01       Impact factor: 4.534

5.  RNA polymerase II inhibitor, 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes.

Authors:  J O Hensold; D Barth; C A Stratton
Journal:  J Cell Physiol       Date:  1996-07       Impact factor: 6.384

6.  Jun blockade of erythropoiesis: role for repression of GATA-1 by HERP2.

Authors:  Kamaleldin E Elagib; Mang Xiao; Isa M Hussaini; Lorrie L Delehanty; Lisa A Palmer; Frederick K Racke; Michael J Birrer; Shanmugasundaram Ganapathy-Kanniappan; Ganapath Shanmugasundaram; Michael A McDevitt; Adam N Goldfarb
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

Review 7.  Cellular control of gene expression by T-type cyclin/CDK9 complexes.

Authors:  Judit Garriga; Xavier Graña
Journal:  Gene       Date:  2004-08-04       Impact factor: 3.688

8.  Coordination of transcription, RNA processing, and surveillance by P-TEFb kinase on heat shock genes.

Authors:  Zhuoyu Ni; Brian E Schwartz; Janis Werner; Jose-Ramon Suarez; John T Lis
Journal:  Mol Cell       Date:  2004-01-16       Impact factor: 17.970

9.  Endothelial-cell-specific regulation of von Willebrand factor gene expression.

Authors:  N Jahroudi; D C Lynch
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice.

Authors:  Lucia Centurione; Angela Di Baldassarre; Maria Zingariello; Domenico Bosco; Valentina Gatta; Rosa Alba Rana; Vincenzo Langella; Antonio Di Virgilio; Alessandro M Vannucchi; Anna Rita Migliaccio
Journal:  Blood       Date:  2004-08-03       Impact factor: 22.113

View more
  25 in total

1.  Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.

Authors:  Sang-Hyun Song; AeRi Kim; Tobias Ragoczy; M A Bender; Mark Groudine; Ann Dean
Journal:  Blood       Date:  2010-06-22       Impact factor: 22.113

2.  Effects of panaxadiol saponins component as a new Chinese patent medicine on proliferation, differentiation and corresponding gene expression profile of megakaryocytes.

Authors:  Wei-Wei Wen; Xin Sun; Hai-Feng Zhuang; Xiao-Jie Lin; Zhi-Yin Zheng; Rui-Lan Gao; Li-Ming Yin
Journal:  Chin J Integr Med       Date:  2015-04-24       Impact factor: 1.978

3.  Neonatal expression of RNA-binding protein IGF2BP3 regulates the human fetal-adult megakaryocyte transition.

Authors:  Kamaleldin E Elagib; Chih-Huan Lu; Goar Mosoyan; Shadi Khalil; Ewelina Zasadzińska; Daniel R Foltz; Peter Balogh; Alejandro A Gru; Deborah A Fuchs; Lisa M Rimsza; Els Verhoeyen; Miriam Sansó; Robert P Fisher; Camelia Iancu-Rubin; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2017-05-08       Impact factor: 14.808

4.  Adult human megakaryocyte-erythroid progenitors are in the CD34+CD38mid fraction.

Authors:  Chad Sanada; Juliana Xavier-Ferrucio; Yi-Chien Lu; Elizabeth Min; Ping-Xia Zhang; Siying Zou; Elaine Kang; Meng Zhang; Gazelle Zerafati; Patrick G Gallagher; Diane S Krause
Journal:  Blood       Date:  2016-06-06       Impact factor: 22.113

5.  A genome-wide RNA interference screen identifies a differential role of the mediator CDK8 module subunits for GATA/ RUNX-activated transcription in Drosophila.

Authors:  Vanessa Gobert; Dani Osman; Stéphanie Bras; Benoit Augé; Muriel Boube; Henri-Marc Bourbon; Thomas Horn; Michael Boutros; Marc Haenlin; Lucas Waltzer
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

Review 6.  Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways.

Authors:  Xiuli Liu; W Lee Kraus; Xiaoying Bai
Journal:  Trends Biochem Sci       Date:  2015-08-04       Impact factor: 13.807

Review 7.  Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.

Authors:  Adam N Goldfarb
Journal:  J Cell Biochem       Date:  2009-06-01       Impact factor: 4.429

8.  Calpain 2 activation of P-TEFb drives megakaryocyte morphogenesis and is disrupted by leukemogenic GATA1 mutation.

Authors:  Kamaleldin E Elagib; Jeremy D Rubinstein; Lorrie L Delehanty; Valerie S Ngoh; Peter A Greer; Shuran Li; Jae K Lee; Zhe Li; Stuart H Orkin; Ivailo S Mihaylov; Adam N Goldfarb
Journal:  Dev Cell       Date:  2013-12-23       Impact factor: 12.270

9.  Isocitrate ameliorates anemia by suppressing the erythroid iron restriction response.

Authors:  Chanté L Richardson; Lorrie L Delehanty; Grant C Bullock; Claudia M Rival; Kenneth S Tung; Donald L Kimpel; Sara Gardenghi; Stefano Rivella; Adam N Goldfarb
Journal:  J Clin Invest       Date:  2013-07-25       Impact factor: 14.808

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.